best companies for glp-1 medication The Next Big Weight Loss Drug Stocks The Next Big Weight Loss

This product is supplied strictly on an informed purchaser basis

Medically supervised GLP-1 weight loss program led by NP Stefanie Drozd

Product amount: 29.77 oz./844g

The battle over America's booming weight-loss drug market has a significant update, with a move thats likely to cause a shift across the healthcare and corporate benefits landscape: Cigna, one of Americas biggest insurers, is dropping coverage for GLP-1 obesity drugs, even for its own staff

Unrealised Expectations Despite progress, several anticipated 2025 milestones did not come to fruition: Regulatory progress stalled: FDAs obesity drug guidance, published in draft form in January 2025, remains unfinalised, whilst EMA has yet to update its 2016 guideline